ASN Kidney Week 2024 – Glomerular Diseases: 2024 Update

• • Glomerular Diseases: 2024 Update

    Location: Ballroom 20D, Convention Center

    Session Description

    Glomerular medicine is exploding with exciting new understanding of disease pathogenesis, which has led to developments in novel genetic and serological diagnostic tools, clinical trials, and potential treatments. This program explores novel changes in IgAN/Henoch-Schonlein purpura, lupus nephritis, podocytopathies (FSGS/minimal change disease), membranous GN, atypical hemolytic uremic syndrome/C3 glomerulopathy, diabetic kidney disease, glomerular disease as “CKD,” and monoclonal gammopathy of renal significance. Hot topics are reviewed, including how and when to use genetics in the diagnosis and treatment of glomerular diseases, chimeric antigen receptor T cell therapy, balancing cost and efficacy of new medications for glomerular diseases, and precision medicine and clinical trials. Experts present cutting-edge clinical applications in treatment, pathology, and genetics that continue to change the diagnostic and therapeutic landscape in glomerular diseases.

    Session Objectives

    Upon completion of this program, the participant will be able to: 1) describe the pathophysiology, pathology, diagnostics, and therapeutic options for glomerular diseases; 2) summarize information from current basic and clinical research studies and apply to the diagnosis and management of glomerular diseases; 3) analyze nuances in the treatment of patients with difficult-to-manage glomerular diseases; and 4) discuss when to use novel medications and/or to enroll patients in clinical trials as medical therapy options.

Learning Pathway(s)

• Glomerular Diseases

Moderators

• Sharon G. Adler, MD, FASN
• John Cijiang He, MD, PhD, FASN

Presentations

• Check In and Continental Breakfast
  07:00 AM PDT – 08:00 AM PDT
  
• Welcome and Introduction
  08:00 AM PDT – 08:10 AM PDT
  
• Treating IgAN and IgA Vasculitis
  08:10 AM PDT – 08:45 AM PDT
  
  • Heather N. Reich, MD, PhD
• Treating Lupus Nephritis in a New Era
  08:45 AM PDT – 09:20 AM PDT
  
  • Brad H. Rovin, MD, FASN
• Treating ANCA-Associated Vasculitis
  09:20 AM PDT – 09:55 AM PDT
  
  • Rachel B. Jones, MD, MBBS
• Break
  09:55 AM PDT – 10:10 AM PDT
  
• Clinicopathologic Conference 1: Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy
  10:10 AM PDT – 10:55 AM PDT
  
  • Elaine S. Kamil, MD
  • Cynthia C. Nast, MD, FASN
• Genetic Testing for Glomerular Diseases: When Do We Need It?
  10:55 AM PDT – 11:30 AM PDT
  
  • Simone Sanna-Cherchi, MD
• Clinicopathologic Conference 2: Podocytopathies
  11:30 AM PDT – 12:15 PM PDT
  
  • J. Ashley Jefferson, MD, FASN
  • Cynthia C. Nast, MD, FASN
• Lunch (on your own)
  12:15 PM PDT – 01:15 PM PDT
  
• Maximizing Supportive Care for Diabetic Kidney Disease and Non-diabetic CKD
  01:15 PM PDT – 01:50 PM PDT
  
  • Sylvia E. Rosas, MD, MS, FASN
• Balancing Cost and Efficacy of New GN Drugs
  01:50 PM PDT – 02:25 PM PDT
  
  • Sean Barbour, MD, MS, MSc
• Understanding and Managing Monoclonal Gammopathy of Renal Significance Spectrum Diseases
  02:25 PM PDT – 03:00 PM PDT
  
  • Nelson Leung, MD
• Break
  03:00 PM PDT – 03:15 PM PDT
  
• Chimeric Antigen Receptor T Cell Therapy for Glomerular Diseases
  03:15 PM PDT – 03:50 PM PDT
  
  • A. Richard Kitching, MBChB, PhD, FASN
• Moving the Glomerular Disease Field Forward with Precision Medicine and Clinical Trials
  03:50 PM PDT – 04:25 PM PDT
  
  • Laura H. Mariani, MD, MS, FASN
• Clinicopathologic Conference 3: Membranous Nephropathy, Infection-Related Glomerulonephritis, and Anti-glomerular Basement Membrane Disease
  04:25 PM PDT – 06:00 PM PDT
  
  • Rupali S. Avasare, MD
  • Glen S. Markowitz, MD